| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |